Chi Sheng Pharma & Biotech Co Ltd

ROCO:4111 (Taiwan)  
NT$ 25.70 (-0.58%) Apr 22
12.73
P/B:
1.20
Market Cap:
NT$ 1.46B ($ 44.88M)
Enterprise V:
NT$ 1.37B ($ 42.05M)
Volume:
106.00K
Avg Vol (2M):
116.03K
Volume:
106.00K
Avg Vol (2M):
116.03K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Chi Sheng Pharma & Biotech Co Ltd ( ) from 1999 to Apr 23 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Chi Sheng Pharma & Biotech stock (ROCO:4111) PE ratio as of Apr 23 2024 is 12.73. More Details

Chi Sheng Pharma & Biotech Co Ltd (ROCO:4111) PE Ratio (TTM) Chart

To

Chi Sheng Pharma & Biotech Co Ltd (ROCO:4111) PE Ratio (TTM) Historical Data

Total 1175
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Chi Sheng Pharma & Biotech PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-04-23 12.7 2024-02-15 12.8
2024-04-22 12.7 2024-02-05 12.8
2024-04-19 12.8 2024-02-02 12.9
2024-04-18 13.0 2024-02-01 12.9
2024-04-17 13.1 2024-01-31 12.9
2024-04-16 13.0 2024-01-30 12.8
2024-04-15 13.0 2024-01-29 12.9
2024-04-12 13.1 2024-01-26 12.8
2024-04-11 13.1 2024-01-25 12.7
2024-04-10 13.2 2024-01-24 12.7
2024-04-09 13.2 2024-01-23 12.7
2024-04-08 13.0 2024-01-22 12.7
2024-04-03 13.0 2024-01-19 12.7
2024-04-02 13.1 2024-01-18 12.7
2024-04-01 13.1 2024-01-17 12.7
2024-03-29 13.0 2024-01-16 12.9
2024-03-28 13.0 2024-01-15 12.9
2024-03-27 13.0 2024-01-12 12.9
2024-03-26 12.9 2024-01-11 12.9
2024-03-25 12.9 2024-01-10 12.8
2024-03-22 12.9 2024-01-09 12.9
2024-03-21 12.8 2024-01-08 13.0
2024-03-20 12.9 2024-01-05 13.0
2024-03-19 12.9 2024-01-04 13.1
2024-03-18 12.9 2024-01-03 13.1
2024-03-15 12.9 2024-01-02 13.1
2024-03-14 12.9 2024-01-01 13.2
2024-03-13 12.9 2023-12-29 13.2
2024-03-12 12.9 2023-12-28 13.1
2024-03-11 12.8 2023-12-27 13.2
2024-03-08 12.9 2023-12-26 13.2
2024-03-07 12.9 2023-12-25 13.1
2024-03-06 12.9 2023-12-22 13.2
2024-03-05 13.0 2023-12-21 13.2
2024-03-04 12.9 2023-12-20 13.3
2024-03-01 13.0 2023-12-19 13.3
2024-02-29 13.0 2023-12-18 13.3
2024-02-27 13.0 2023-12-15 13.2
2024-02-26 13.0 2023-12-14 13.2
2024-02-23 12.9 2023-12-13 13.2
2024-02-22 13.0 2023-12-12 13.2
2024-02-21 13.1 2023-12-11 13.2
2024-02-20 13.0 2023-12-08 13.1
2024-02-19 13.0 2023-12-07 13.2
2024-02-16 13.0 2023-12-06 13.3

Chi Sheng Pharma & Biotech Co Ltd (ROCO:4111) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Chi Sheng Pharma & Biotech Co Ltd manufactures and distributes medical medicines and equipment in Taiwan. It offers injections, including hemodialysis solutions, amino acid injections, vitamin injections, and externally applied medicines.